Patent ID: 8334255

Claim:
A compound according to the formula I: X 1 -M-SEQ ID NO:1 (I) or a pharmaceutically acceptable salt thereof wherein: X 1 -M- represents an optional group comprising, a protein transduction domain conjugated to the N-terminus of the amino acid sequence SEQ ID NO:1, wherein: X 1 represents the protein transduction domain; -M- represents a single bond or an optional linking group forming a covalent linkage between the protein transduction domain and the amino acid sequence SEQ ID NO:1; and the protein transduction domain comprises an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, and SEQ ID NO:34; provided that if the compound comprises an amino acid directly bound to the N-terminus of the amino acid sequence SEQ ID NO:1, then the amino acid directly bound to the N-terminus is other than asparagine.